|Bid||6.25 x 800|
|Ask||6.30 x 2900|
|Day's Range||6.23 - 6.49|
|52 Week Range||4.95 - 16.39|
|Beta (5Y Monthly)||1.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 11, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||18.67|
Preliminary results of phase I clinical trial yields high titers of SARS-CoV-2 neutralizing antibodies from all cohort members.
Applied DNA CEO discusses relevance of DNA-based cotton traceability in textile manufacturing in interview with BBC.
Applied DNA Sciences (APDN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.